SLNCF
Price
$2.00
Change
-$0.25 (-11.11%)
Updated
Dec 26 closing price
Capitalization
283.4M
Intraday BUY SELL Signals
SOLTF
Price
$4.91
Change
-$0.17 (-3.35%)
Updated
Dec 26 closing price
Capitalization
484.97M
Intraday BUY SELL Signals
Interact to see
Advertisement

SLNCF vs SOLTF

Header iconSLNCF vs SOLTF Comparison
Open Charts SLNCF vs SOLTFBanner chart's image
Silence Therapeutics
Price$2.00
Change-$0.25 (-11.11%)
Volume$200
Capitalization283.4M
Nxera Pharma
Price$4.91
Change-$0.17 (-3.35%)
Volume$804
Capitalization484.97M
SLNCF vs SOLTF Comparison Chart in %
SLNCF
Daily Signal:
Gain/Loss:
SOLTF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SLNCF vs. SOLTF commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLNCF is a Buy and SOLTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (SLNCF: $2.00 vs. SOLTF: $4.91)
Brand notoriety: SLNCF and SOLTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLNCF: 53% vs. SOLTF: 141%
Market capitalization -- SLNCF: $283.4M vs. SOLTF: $484.97M
SLNCF [@Biotechnology] is valued at $283.4M. SOLTF’s [@Biotechnology] market capitalization is $484.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLNCF’s FA Score shows that 1 FA rating(s) are green whileSOLTF’s FA Score has 0 green FA rating(s).

  • SLNCF’s FA Score: 1 green, 4 red.
  • SOLTF’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNCF is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLNCF’s TA Score shows that 4 TA indicator(s) are bullish while SOLTF’s TA Score has 4 bullish TA indicator(s).

  • SLNCF’s TA Score: 4 bullish, 3 bearish.
  • SOLTF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both SLNCF and SOLTF are a good buy in the short-term.

Price Growth

SLNCF (@Biotechnology) experienced а -1.47% price change this week, while SOLTF (@Biotechnology) price change was -8.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($485M) has a higher market cap than SLNCF($283M). SOLTF YTD gains are higher at: -20.260 vs. SLNCF (-23.810). SOLTF has higher annual earnings (EBITDA): 854M vs. SLNCF (-81.06M). SOLTF has more cash in the bank: 33B vs. SLNCF (102M). SLNCF has less debt than SOLTF: SLNCF (182K) vs SOLTF (64.7B). SOLTF has higher revenues than SLNCF: SOLTF (31.2B) vs SLNCF (25.8M).
SLNCFSOLTFSLNCF / SOLTF
Capitalization283M485M58%
EBITDA-81.06M854M-9%
Gain YTD-23.810-20.260118%
P/E RatioN/AN/A-
Revenue25.8M31.2B0%
Total Cash102M33B0%
Total Debt182K64.7B0%
FUNDAMENTALS RATINGS
SLNCF vs SOLTF: Fundamental Ratings
SLNCF
SOLTF
OUTLOOK RATING
1..100
3883
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3882
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLNCF's Valuation (31) in the null industry is somewhat better than the same rating for SOLTF (92). This means that SLNCF’s stock grew somewhat faster than SOLTF’s over the last 12 months.

SLNCF's Profit vs Risk Rating (100) in the null industry is in the same range as SOLTF (100). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

SLNCF's SMR Rating (98) in the null industry is in the same range as SOLTF (98). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

SLNCF's Price Growth Rating (38) in the null industry is somewhat better than the same rating for SOLTF (82). This means that SLNCF’s stock grew somewhat faster than SOLTF’s over the last 12 months.

SLNCF's P/E Growth Rating (100) in the null industry is in the same range as SOLTF (100). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLNCFSOLTF
RSI
ODDS (%)
Bearish Trend 1 day ago
58%
Bullish Trend 1 day ago
54%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
52%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
49%
MACD
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
45%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
55%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
50%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
61%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
SLNCF
Daily Signal:
Gain/Loss:
SOLTF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUPX20.520.02
+0.10%
NYLI PineStone U.S. Equity Class P
FGSCX24.880.02
+0.08%
Federated Hermes MDT Mid Cap Growth C
TSWMX11.39N/A
N/A
TSW Emerging Markets Institutional
FSSLX13.85N/A
N/A
Fidelity Series Small Cap Core
CGEOX18.23-0.01
-0.05%
Calamos Global Equity R6

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and ENVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and ENVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
-11.11%
ENVB - SLNCF
29%
Poorly correlated
-11.42%
RNXT - SLNCF
24%
Poorly correlated
-4.56%
SOLTF - SLNCF
9%
Poorly correlated
-3.25%
PVCT - SLNCF
8%
Poorly correlated
-0.39%
PXXLF - SLNCF
8%
Poorly correlated
N/A
More

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
-3.25%
BIESF - SOLTF
35%
Loosely correlated
N/A
BSFAF - SOLTF
29%
Poorly correlated
N/A
SPHRF - SOLTF
23%
Poorly correlated
N/A
SLNCF - SOLTF
9%
Poorly correlated
-11.11%
SPHDF - SOLTF
5%
Poorly correlated
N/A
More